• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Effect of income level on stroke incidence and the mediated effect of simultaneous diagnosis of metabolic syndrome diseases; a nationwide cohort study in South Korea
This study aimed to determine whether a simultaneous diagnosis of main components of metabolic syndrome (MetS) (hypertension, diabetes mellitus, and dyslipidemia) plays a mediator between income level and stroke.
Source: Diabetology and Metabolic Syndrome - August 8, 2022 Category: Endocrinology Authors: Seungmin Jeong, Sung-il Cho and So Yeon Kong Tags: Research Source Type: research

10-Year Mortality Trends for Adults with and without Diabetes Mellitus in South Korea, 2003 to 2013.
CONCLUSION: All-cause and cardiovascular mortality rates decreased substantially from 2003 to 2013, and the decline in ischemic stroke mortality mainly contributed to the decreased cardiovascular mortality in Korean people with diabetes. PMID: 29885109 [PubMed - as supplied by publisher]
Source: Diabetes and Metabolism Journal - June 11, 2018 Category: Endocrinology Tags: Diabetes Metab J Source Type: research

Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
Diabetes Metab. 2023 Jan 3:101418. doi: 10.1016/j.diabet.2022.101418. Online ahead of print.ABSTRACTBACKGROUND: Continued expansion of indications for sodium-glucose cotransporter-2 inhibitors increases importance of evaluating cardiovascular and kidney efficacy and safety of empagliflozin in patients with type 2 diabetes compared to similar therapies.METHODS: The EMPRISE Europe and Asia study is a non-interventional cohort study using data from 2014-2019 in seven European (Denmark, Finland, Germany, Norway, Spain, Sweden, United Kingdom) and four Asian (Israel, Japan, South Korea, Taiwan) countries. Patients with type 2 d...
Source: Diabetes and Metabolism - January 7, 2023 Category: Endocrinology Authors: Avraham Karasik Stefanie Lanzinger Elise Chia-Hui Tan Daisuke Yabe Dae Jung Kim Wayne H-H Sheu Cheli Melzer-Cohen Reinhard W Holl Kyoung Hwa Ha Kamlesh Khunti Francesco Zaccardi Anuradhaa Subramanian Krishnarajah Nirantharakumar Thomas Nystr öm Leo Niska Source Type: research

Actinic keratosis and diabetes complications: A nationwide population-based study in South Korea (2009-2015).
CONCLUSION: This study has revealed that the incidence of AK is higher in diabetes patients with ocular, renal and cardiovascular complications. PMID: 29249611 [PubMed - as supplied by publisher]
Source: Diabetes and Metabolism - November 29, 2017 Category: Endocrinology Authors: Bok Lee Y, Hyun Lee J, Young Choi J, Soo Yu D, Do Han K, Gyu Park Y Tags: Diabetes Metab Source Type: research

Pre-existing Depression among Newly Diagnosed Dyslipidemia Patients and Cardiovascular Disease Risk.
CONCLUSION: Dyslipidemia patients with pre-existing depression had increased risk for CVD. Future studies that determine CVD risk after management of depression among dyslipidemia patients are needed. PMID: 31701694 [PubMed - as supplied by publisher]
Source: Diabetes and Metabolism Journal - November 10, 2019 Category: Endocrinology Tags: Diabetes Metab J Source Type: research

Risk of Incident Dementia According to Glycemic Status and Comorbidities of Hyperglycemia: A Nationwide Population-Based Cohort Study
CONCLUSIONSMild degrees of hyperglycemia and presence of comorbidities were associated with incident dementia. Intervention during the prodromal stage of a chronic disease (e.g., prediabetes) could be considered for dementia prevention.
Source: Diabetes Care - October 28, 2021 Category: Endocrinology Source Type: research

Empagliflozin is associated with lower risk of cardiovascular events and all ‐cause mortality in routine care in East Asia: Results from the EMPRISE study
ConclusionsThe results suggest that both empagliflozin and SGLT2i compared with DPP-4i are associated with a lower risk of cardiovascular events and all-cause mortality in routine clinical care in East Asia.
Source: Journal of Diabetes Investigation - January 31, 2023 Category: Endocrinology Authors: Dae Jung Kim, Wayne H ‐H Sheu, Wook‐Jin Chung, Daisuke Yabe, Kyoung Hwa Ha, Masaomi Nangaku, Elise Chia‐Hui Tan, Koichi Node, Atsutaka Yasui, Weiyu Lei, Sunwoo Lee, Laura Saarelainen, Anouk Deruaz‐Luyet, Moe H Kyaw, Yutaka Seino, EM Tags: ORIGINAL ARTICLE Source Type: research

Association between antidiabetic drugs and the incidence of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in South Korea
Atrial fibrillation (AF) is clinical practice's most common sustained cardiac arrhythmia. The prevalence of AF increases with age; thus, the incidence and prevalence of AF are increasing in the aging population worldwide. [1] AF is a significant risk factor for cardiovascular disease (CVD), ischemic stroke, and mortality, resulting in a substantial economic burden and significant morbidity and mortality. [2,3] Thus, it is essential to identify and intervene against the modifiable risk factors to reduce the risk of developing AF.
Source: Diabetes Research and Clinical Practice - March 16, 2023 Category: Endocrinology Authors: Sunyoung Kim, So Young Park, Bongseong Kim, Chanyang Min, Wonyoung Cho, Dong Keon Yon, Joo Young Kim, Kyung-Do Han, Eun-Jung Rhee, Won-Young Lee, Sang Youl Rhee Source Type: research